key: cord-0719312-mfebtht9
authors: Rocha-Romero, Andrés; Roychoudhury, Priodarshi; Carvajal, Gabriel
title: Facing postdural puncture headache in COVID-19 times
date: 2020-10-27
journal: Reg Anesth Pain Med
DOI: 10.1136/rapm-2020-102175
sha: 9a8c30c9a45c06bfc6fa8e64b38fda3391c60ab4
doc_id: 719312
cord_uid: mfebtht9

nan

To the Editor We read with great interest the recent report by Levin and Cohen 1 describing safe, simple and inexpensive methods to administer the sphenopalatine ganglion block (SGB). We are aware of their previous work showing a faster relief by SGB and fewer complications than epidural blood patch (EBP). 2 Considering some patients may not be candidates to EPB for medical o religious reasons, we have favored a self-applied SGB technique 3 obtaining satisfactory results.

Nevertheless, EBP is not always avoided. A recent study by Jespersen et al, 4 comparing SGB with sham block (saline) showed no statistically significant difference in pain intensity 30 min after the block. We think that the best approach (like in every pain management) must be multimodal. Relying on one single method to treat pain is not the best option. We have perceived positive effects of SGB for postdural puncture headache concordant with other studies and still practice it particularly in COVID-19 times, thus avoiding blood contact and sometimes an operating room.

Currently, our multimodal approach includes the addition of intravenous neostigmine and atropine as described in 2018. 5 These drugs depolarize cervical sympathetic ganglia, block sphenopalatine ganglion (again), and regulate vascular tone and cerebrospinal fluid secretion. SGB combined with 20 µg/kg neostigmine and 10 µg/kg atropine in 20 mL of 0.9% saline given over 5 min intravenously every 8 hours remains a practical and noninvasive option.

Thankfully, nowadays, we have few patients requiring this multimodal management, but excellent results are coming. We encouraged anesthesiologists to avoid EBP in times of pandemic and opt for a multimodal approach that includes non-invasive SGB and evidence-based pharmacological treatment. Contributors AR: helped in conception, design, analysis and interpretation of data and manuscript writing. PR: helped in analysis and interpretation of data and manuscript writing. GC: helped in design, analysis and interpretation of data and manuscript writing.

Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

Images in anesthesiology: three safe, simple, and inexpensive methods to administer the sphenopalatine ganglion block

Topical sphenopalatine ganglion block compared with epidural blood patch for postdural puncture headache management in postpartum patients: a retrospective review

Self-applied sphenopalatine ganglion block for postdural puncture headache: four case reports

Sphenopalatine ganglion block for the treatment of postdural puncture headache: a randomised, blinded, clinical trial

Addition of neostigmine and atropine to conventional management of postdural puncture headache: a randomized controlled trial

Patient consent for publication Not required.Provenance and peer review Not commissioned; internally peer reviewed.This article is made freely available for use in accordance with BMJ's website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.